Dr Mark Kris highlights a recent study on osimertinib in NSCLC and outlines the best approaches for treatment beyond progression.
The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects.
The top stories in non-small cell lung cancer (NSCLC) for 2024 included practice-changing results in EGFR-mutant disease, an unprecedented gain in progression-free survival (PFS) for ALK-positive ...
A new drug combo recently approved by the Food & Drug Administration can halt lung cancer in its treacherous tracks — for over 40% longer than previously possible, a wide-ranging trial funded by ...
Spatial maps of lung precancer and cancer cells at different points in development advance understanding of the earliest stages of lung cancer Findings highlight inflammation as a driver of lung tumor ...
It can be surprising to learn that lung cancer can develop in people who have never smoked. In fact, up to 20% of lung ...
February 2026 coverage highlighted combination EGFR therapy guidance, chemo-free treatment options, biomarker testing and ...
Everyday Health on MSN
Severe Flu or COVID-19 Could Raise Lung Cancer Risk
In a new study, researchers found that being hospitalized for flu or COVID-19 was linked to a 24 percent increase in later lung cancer risk. Learn how to protect yourself.
A recent study has found that severe cases COVID-19 or influenza can leave lasting changes in the lungs that increase the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results